Cargando…
Post-ERCP Pancreatitis: Risk factors and role of NSAIDs in primary prophylaxis
OBJECTIVE: To determine efficacy of diclofenac suppository in reducing post-ERCP pancreatitis (PEP) and identify risk factors for PEP. METHODS: This is a placebo-based prospective study at Department of Medicine & Gastroenterology, Services Institute of Medical Sciences / Services Hospital, Laho...
Autores principales: | Nawaz, Muhammad Haseeb, Sarwar, Shahid, Nadeem, Muhammad Arif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Professional Medical Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150400/ https://www.ncbi.nlm.nih.gov/pubmed/32292447 http://dx.doi.org/10.12669/pjms.36.3.1804 |
Ejemplares similares
-
Prevention of post-ERCP pancreatitis: NSAID or pancreatic stent or both?
por: van Wanrooij, R. L. J., et al.
Publicado: (2019) -
Primary prophylaxis of hepatic encephalopathy in decompensated cirrhosis: Low dose vs. full dose rifaximin
por: Sarwar, Shahid, et al.
Publicado: (2019) -
The synergistic impact of NSAIDs and aggressive hydration therapy on the rate of post-ERCP pancreatitis in high -risk and low -risk patients
por: Aghajanpoor Pasha, Morteza, et al.
Publicado: (2020) -
Post-ERCP Pancreatitis: Prevention, Diagnosis and Management
por: Cahyadi, Oscar, et al.
Publicado: (2022) -
Post-ERCP acute pancreatitis and its risk factors
por: Iorgulescu, A, et al.
Publicado: (2013)